Research and Development

Research and Development

Patent portfolio

Biomarker and diagnostics portfolio

1. Prognostic and Diagnostic Glycan-based Biomarkers of Brain Damage

  • European patent No. 3283880
    US patent No. 10,739,335
    Canadian patent No. 2,982,503
    Israeli patent No. 254 980

2. Non-invasive Brain Injury Diagnostic Device

  • PCT application WO/2018/154,401, has entered into national phases
    South African patent (number pending)
    Utility model granted in China and Australia

3. Device and Method for Detecting of Brain injury in a Subject

  • PCT application WO 2021/099677
    Australian patent No. 2020104474
  • Finnish Utility model No. 1317

4. A Method for Determining a Lectin-binding Glycan Indicative To Traumatic Brain Injury

  • PCT application WO 2021/205059

5. A Method for Diagnosis of Traumatic Brain Injury

  • PCT-application PCT/FI2023/050076

6. Method of Detecting Tissue Damage

  • PCT-application PCT/FI2022/050805

7. A Hand-held Liquid Sample Collection and Testing Device

  • Finnish utility model No. 13331
  • German and Austrian utility models pending

Drug development portfolio

1. Multivalent Compounds for Use in the Treatment and Prevention of Brain Damage

  • US patent No. 9,975,846
    Finnish patent No. 127024
    Israeli patent No. 251407
    European patent No. 3201173

2. Conjugates and Conjugates for Use in Preventing or Treating of Brain Damage and Neurodegenerative Diseases

  • PCT application WO 2021/038125

Other patents 

1. Method for Determining Coronavirus and Kit for the Same

  • PCT application WO 2021/205058